Summary.-Leukaemic cells from rats with a lymphoid (HRL) or myeloid (SAL) leukaemia were labelled with 125IUDR and injected i.v. into either normal or leukaemic syngeneic recipients. The fate of the injected cells was studied in terms of the radioactivity in various tissues at various times up to 24 h later.
leukaemia were labelled with 125IUDR and injected i.v. into either normal or leukaemic syngeneic recipients. The fate of the injected cells was studied in terms of the radioactivity in various tissues at various times up to 24 h later.
In normal animals the leukaemia cells were destroyed rapidly in the reticuloendothelial (RE) system; immediately after injection most recoverable activity was in the lung, with smaller amounts in the blood, spleen and liver but by 24 h only 20-30% of the injected activity could be recovered.
In leukaemic recipients with high numbers of blasts in the blood the amount of activity recoverable from the lungs and bone-marrow was markedly reduced, while that in the blood was doubled. Nonetheless, the overall rate at which radioactivity was eliminated was not significantly different from that found in normal rats, in spite of the fact that the RE system was extensively infiltrated by leukaemia cells.
SEVERAL studies have shown that when radio-labelled viable tumour cells are injected intravenously (i.v.) into syngeneic recipients the great majority are trapped and killed in the lung, liver and spleen (Selecki, 1959; Hofer, Prensky and Hughes, 1969; Fidler, 1970 Fidler, , 1973 . The fraction of cells which survives injection by the i.v. route and causes tumours is very small and less than that found for cells given intraperitoneally or subcutaneously (Hofer et al., 1969) . The majority of tumour cells trapped in the lung lyse within a few hours and if radio-labelled in their DNA the label appears in the urine in the form of low molecular weight substances. The mechanism for this rapid destruction of tumour cells in the lung is not known, but it seems unlikely that an immunological reaction of the host directed against tumour-specific surface antigens can be involved, as the rate of destruction is modified only slightly by immunosuppression or prior immunization (van den Brenk et al., 1975; Weiss, Glaves and Waite, 1974) . The extent and rate at which labelled i.v.-inoculated tumour cells are killed by the reticuloendothelial (RE) system is very much greater than that of similarly injected radio-labelled lymphocytes (Shorter and Bollman, 1960; Woodruff and Gesner, 1969) . This raises the possibility that the RE system may have a means of discriminating between malignant and non-malignant cells. Indeed, macrophages that have been activated by, for example, endotoxin, kill lymphoma and sarcoma cells in vitro (Alexander and Evans, 1971; Hibbs, Lambert and Remington, 1972) . There is evidence that this mechanism contributes to the in vivo destruction of some tumours by endotoxin (Parr, Wheeler and Alexander, 1973) and other agents that render macrophages non-specifically cytotoxic. In particular, the increased resistance of the lungs to i.v. challenge with tumour cells which is observed when rodents are treated with Corynebacterium parvrum (Proctor, Rudenstam and Alexander, 1973; van Putten et al., 1975) may be attributed to increased tumouricidal potential of lung macrophages.
The concept that the RE system, and in particular the lung, recognizes malignant cells through a characteristic surface property implies that such a mechanism is impaired when there are cells circulating in the blood as in leukaemic animals.
To test this hypothesis, the fate and rate of death of i.v.-inoculated leukaemia cells were studied in rats, using two transplantable acute leukaemias which arose spontaneously. The HRL leukaemia is an acute lymphoblastic leukaemia and the SAL an acute myelogenous leukaemia (Wrathmell and Alexander, 1973; Wrathmell, 1976 (Hughes et al., 1964; Fidler, 1970) . They were incubated for 1 h with 0-1 ,C/ml at 38°C, washed 3 times centrifuging for 5 min at 240 g and finally suspended at concentrations of 108 cells/ml (Hall and Smith, 1970 (Schneider, 1945) indicated that approximately 75% of the activity associated with the leukaemia cells was attached to the DNA.
Rats were injected whilst under light ether anaesthesia with 0 5 ml of tissue culture fluid containing 5 x 107 cells in the lateral tail vein.
125IUDR in vivo.-Thirteen days after the inoculation of leukaemia cells, hooded rats were given 150 ,uC 125IUDR i.v. at 0 and 8 h. The rats were exsanguinated at 24 h and 0 5 ml volumes of blood were immediately injected into recipient rats.
3H-thymidine in vitro.-When tissue autoradiographs were required, 3H-thymidine (Radiochemical Centre, Amersham, specific activity 23 Ci/mmol) was used as the label. The cells were treated as for in vitro 125JUDR-labelling except that they were incubated with 1,uC/ml 3H-thymidine for 1 h at 38°C (Hall and Smith, 1970) .
Heat-killed cells.-Labelled cells were killed by heating in a 55°C water bath for 45 min. They were washed before transfusion.
Collection of material for radioassay and counting procedures.-Recipient rats were killed in groups of 5 at various intervals from nominally zero time (1-5 min) to 24 h after injection of 1251UDR-labelled cells.
In every case the following tissues were removed: lung, liver, spleen, small gut (flushed of contents), thymus, lymph nodes (mesenteric, mediastinal, superficial and deep cervical), bone marrow (as femur), and blood taken by cardiac puncture. In a few cases the whole rat was dissected. The tissues were cleared of connective tissue and fat, washed in normal saline and blotted dry before weighing and placing in a counting vial. Blood was divided into 2 samples, one left whole, the other centrifuged and the serum removed for counting. The radioactivity in each vial was counted in a Packard model 3002 Auto-Gamma scintillation spectrometer. Counting rates that were no more than 2 standard deviations above replicate blank values were scored as having no activity. The activity in each whole organ was expressed as a percentage of the radioactivity injected. The total activity in the bone marrow was expressed as the activity in one femur multiplied by 10 and that in the blood was calculated as ct/min/ ml x 10 (Wang, 1959) .
When 3H-thymidine-labelled cells had been injected, the lung, liver and spleen were removed from recipient rats, fixed in formol saline and subjected to standard histologic and autoradiographic techniques. The recovery of activity in 30 hooded rats, killed in groups of 5 at various intervals after the injection of in vitro 1251UDR-labelled HRL cells, is shown in the upper part of Fig. 1 . Immediately after injection the highest activity, 36% of that injected, was found in the lung and 9% was recovered from the blood. However, 40% of the blood radioactivity was found to be in the serum, indicating that at least this amount was not attached to the injected cells. The activity recovered in the lung and blood decreased with time, whilst that in the liver increased to a maximum at 2 and 4 h after injection, of about 17% of that injected. The total radioactivity recovered from the lung, liver, spleen and gut fell progressively with time and by 24 h only 7.5% of the total activity injected could be detected in these organs (Fig. 2) . The counts in the bone marrow (activity in one femur x 10) were relatively high and increased to a maximum at 2-4 h after injection (Table) .
A few rats were killed at 4 and 24 h, totally dissected, and the activity present in the various tissues of the whole animal counted. In the 4-h rats 7.5% of the activity injected was found in the kidney and bladder fraction, indicating a high 1251 excretion; and in the 24-h rats 10% was found in the thyroid, which binds free iodine. There was some radioactivity throughout the other tissues but this was much too low to indicate that there was significant homing to tissues other than those routinely sampled.
Autoradiographic studies of the lung, liver and spleen after the injection of 3H-labelled HRL cells showed that at 0*5 h after their injection a few cells were present in the peripheral capillaries of the terminal alveoli of the lung, and some cells which appeared damaged were in the liver. At 4 h the liver showed a scattering of label with few intact labelled cells, and in the spleen there were a few labelled cells in the red pulp but none in the white pulp.
The recovery of radioactivity from the viscera of recipients which had received heat-killed labelled HRL cells is also shown in Fig. 2 . The loss of injected activity was more rapid from these animals than from those that had received labelled viable cells. The activity that was recovered was found mainly in the lungs and liver. It was notable that more heat-killed cells were found in the lungs (36% at 0 5 h after injection) than labelled viable cells (16%). and which had 5 x 105 blast cells/mm3 blood. There was a different distribution of labelled cells in the leukaemic than in the normal rats ( Fig. 1 and 2) . The initial retention in the lungs was very much less than in normal rats and the level in the blood very much higher. Indeed, the blast cells circulated in the blood for a much longer period in the leukaemic rats, as can be seen in Fig. 3 Figure 4 shows the distribution of activity after the i.v. injection of cells. Immediately after injection, 60%o of the activity injected was recovered from the lung. With time, the activity in the lung decreased, whilst that in the liver (14%) and blood (8%) increased to a maximum at 05 and 2 h after injection, respectively. Activity recovered from the bone marrow was at a maximum at 2-4 h after injection (Table) . Thereafter the activity recovered from these tissues decreased. Radioactivity in the small gut, thymus and lymph nodes was low. In rats totally dissected and counted, no tissues other than those routinely sampled, excepting was reduced to half and blood was more than d and 4). The activity i the bone marrow was on that found for normal However, the rate at v held in the viscera were significantly different in leukaemic rats from that in normal rats (Fig. 5) .
DISCUSSION
The fates of two i.v.-injected leukaemia blast cell populations, lymphoid (HRL) and myeloid (SAL), were determined in normal and leukaemic recipients. The cells were routinely labelled in vitro with 1251UDR. This analogue of thymidine is incorporated exclusively into the DNA of proliferating cells, is released only on cell death and is not re-utilized (Hughes et al., 1964; Commerford, 1965) .
The characteristic feature of both of the leukaemias studied was the rapid rate at which the i. in the case of the myeloid leukaemia 65% of the injected cells were trapped in the lung. For the lymphatic leukaemia ,were found to the extent of the immediate sequestration he decrease in in the lung was less, possibly because the the viscera with HRL cells were smaller. Over the first There was a 4 h after injection the radioactivity in of heat-killed liver, spleen and bone marrow increased for both SAL and HRL, suggesting that some of the cells that were trapped in SAL cells in the lung succeeded in escaping to these tissues. This movement was more Ere injected into marked with the HRL than the SAL aemia, induced and at 4 h the residual radioactivity in cells 6-7 days the lung corresponded to 15% for SAL and ng in the lung only 2 % for the HRL. While there the level in the was a difference in distribution of activity loubled ( Fig. 3 between lung, liver and spleen for the recovered from two leukaemias, the rate at which the rly one-third of radioactive material was eliminated from rats (Table) . these organs was almost exactly the same vhich the cells (compare Figs. 2 and 5) . However, the lysed was not elimination of radioactivity from the blood was faster for SAL than for HRL (Fig. 3) .
These migratory patterns of the two leukaemia blast cells differ profoundly from that of normal immunoblasts obtained from the rat thoracic duct (Hall and Smith, 1970) . On i.v. injection, the latter are arrested for a short period in the lungs and then home preferentially to the small gut where at 4 h 20% of the total radioactivity can be recovered. Secondarily, they migrate to lymph nodes and spleen.
The fate of i.v.-injected labelled leukaemic cells was studied in rats whose blood count was high, and which were within 2-3 days of death from leukaemia. The principal effect of the pre-existing leukaemias for both SAL and HRL was to halve the fraction of cells that were trapped in the lung immediately after injection (see Figs. 1 and 4) , to reduce the uptake in the bone marrow (Table) , and to double the number of cells that remained in the blood (Fig. 3) . This suggests that the reactions which result in the immediate trapping in the lung of the injected cells and their later sequestration in the bone marrow were impaired by the disease, which was far advanced. A consequence of the reduced trapping was that the number of leukaemia cells which remained in the circulation was greatly increased and in the leukaemic rats constituted a significant proportion of the total injected material (Fig. 3) . A similar observation has been made in man; Stryckmans et al. (1968) found that a large number of autotransfused human leukaemia cells continued to circulate in the blood for at least 24-48 h after their injection.
A surprising finding was that the rate at which radioactivity was eliminated from the RE system (i.e. lung, spleen and liver) was not significantly different from that in normal rats. If the injected labelled cells truly mimic the behaviour of the unlabelled leukaemia cells in the leukaemic rats, these results suggest that the RE system in such rats destroys leukaemic cells at a very high rate, in spite of the fact that the organs are extensively infiltrated. Taken at face value, the results of the comparison of leukaemic with normal rats imply (1) that, for both SAL and HRL, progress of the leukaemia is associated with a decrease *in the initial trapping in the lung of the circulating cells and a reduction in the later sequestration of cells in the bone marrow; these effects may contribute to the very sudden increase in cells in the blood as the disease advances, and (2) that even when the disease is very advanced, the death rate of both HRL and SAL cells within the RE system is very high. However, caution must be exercised in equating the behaviour of injected radio-labelled cells with the leukaemia cells actually within the rats and it is possible that the damage sustained during labelling in vitro may have rendered the injected cells more susceptible to control by the RE system.
